P.A.W. Capital Corp Orchard Therapeutics PLC Transaction History

P.A.W. Capital Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 08, 2020	SELL	$5.65 - $15.71 $395,500 - $1.1 Million	-70,000 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$10.15 - $15.58 $710,500 - $1.09 Million	70,000 New	70,000 $963,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.